A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Topcon Healthcare and OphtAI Announce their Partnership in EMEA

Topcon Healthcare Solutions EMEA Oy (Topcon Healthcare), a leading provider of medical devices and software solutions for the global eye care community, and OphtAI, a joint venture specialised in Artificial Intelligence (AI) for ophthalmology, are pleased to announce their partnership. The partnership will see OphtAI integrated into Topcon’s vendor-neutral data management solution, Harmony Referral System (Harmony), and provide eye care professionals smarter access to AI services.

The state-of-the-art OphtAI Artificial Intelligence algorithm assists eye care professionals in detecting eye pathologies such as diabetic retinopathy and its gradation, macular edema, glaucoma, and AMD at an early stage within only a few seconds, and with only one colour fundus image.

As a result of the partnership, eye care professionals can now enjoy access to OphtAI from Harmony, regardless of which colour fundus device they might be using. Topcon Harmony is a vendor-neutral data management platform, meaning it can be connected to any device, regardless of manufacturer. Harmony gives eye care professionals the flexibility to choose the best devices for their business whilst simultaneously streamlining their clinical workflow by facilitating a single-screen review of all data. Harmony supports vendor-neutral connectivity to devices and Patient Management Systems (PMS) as well as other 3rd party software solutions, providing eye care professionals with workflows designed to answer the specific needs of their clinic or organisation. For Topcon, the partnership with OphtAI strengthens the already existing AI service portfolio that is offered via the platform’s Artificial Intelligence (AI) Marketplace. Through the AI Marketplace, Harmony customers can choose their preferred AI partner and access the automatic image analysis tool of their choice with one single click, straight from the Harmony viewer.

”At Topcon Healthcare, we provide eye care professionals globally with access to innovative solutions for enhanced patient care and effective workflows. This partnership with OphtAI provides our customers with another solution that can help improve efficiency and drive better patient outcomes by making the latest technology an accessible and easy to use part of their everyday workflow.” states Riina Rautee, Director, Sales & Business Development, EMEA for Topcon Healthcare.

”To fully unleash the potential of Artificial Intelligence within the eye care industry, it has to be smartly integrated into the tools that eye care professionals use daily in their clinical workflow. From that perspective, the integration of OphtAI into Harmony is a success. It enables us to bring AI as close as possible to the patients that need it and deliver a higher value proposition to the Optometrists and Ophthalmologists by utilising Topcon’s solutions.” says Alexandre Le Guilcher, OphtAI CEO.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy